NIFTY 50 23344.75 ▲ (0.61%)
NIFTY NEXT 50 65106.15 ▲ (0.08%)
NIFTY 100 24048.8 ▲ (0.51%)
NIFTY MIDCAP 100 55106.2 ▲ (0.91%)
NIFTY SMALLCAP 100 17864.65 ▲ (1.09%)
NIFTY SMALLCAP 250 16841.4 ▲ (0.84%)
NIFTY MIDCAP SELECT 12356.5 ▲ (0.87%)
NIFTY TOTAL MARKET 12304.6 ▲ (0.6%)
NIFTY BANK 49350.8 ▲ (1.67%)
SENSEX 77073.44 ▲ (0.59%)
BSE BANKEX 56036.23 ▲ (2.03%)

SMS Lifesciences India : Q4 2024 Financial Quarterly Report : YoY Sales Up 41.21 %, QoQ Up 24.9 %

June 14, 2024June 14, 2024| adminadmin| 0 Comments| 6:20 pm
Image is loading
Categories:

Share the post "SMS Lifesciences India : Q4 2024 Financial Quarterly Report : YoY Sales Up 41.21 %, QoQ Up 24.9 %"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • Sales over the Year and quarter: The company experienced a substantial growth of 41.21 % in the past year, substantial increase in net sales/revenue by 24.9 %.
  • Income over the Year and quarter: There has been decline in other income over the past year which is -3.27 %, Marginal increase in other income during this quarter, up by 308.62%.
  • Profit over the Year and quarter: Significant improvement in profitability for SMS Lifesciences India Ltd. Notable increase of 206.44 % in net profit Year to Year, SMS Lifesciences India Ltd’s profitability increased by 57.05 % in this quarter.
  • EPS over the Year and quarter: EPS increased by 245.05 % Year to Year. EPS increased by 37.15 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of SMS Lifesciences India Ltd”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 63.731 Cr Rs. 72.053 Cr Rs. 89.992 Cr + 24.9 % + 41.21 %
Expenses Rs. 61.45 Cr Rs. 62.76 Cr Rs. 78.63 Cr + 25.29 % + 27.96 %
Operating Profit Rs. 2.28 Cr Rs. 9.29 Cr Rs. 11.36 Cr + 22.28 % + 398.25 %
OPM % 3.58 % 12.89 % 12.62 % -0.27 % + 9.04 %
Other Income Rs. 2.45 Cr Rs. 0.58 Cr Rs. 2.37 Cr + 308.62 % -3.27 %
Interest Rs. 1.8 Cr Rs. 2.34 Cr Rs. 2.84 Cr + 21.37 % + 57.78 %
Depreciation Rs. 2.92 Cr Rs. 3.73 Cr Rs. 3.78 Cr + 1.34 % + 29.45 %
Profit before tax Rs. 0.01 Cr Rs. 3.8 Cr Rs. 7.11 Cr + 87.11 % + 71000 %
Tax % 10.73 % 8.22 % 8.83 % + 0.61 % -1.9 %
Net Profit Rs. 2.11 Cr Rs. 4.12 Cr Rs. 6.48 Cr + 57.28 % + 207.11 %
EPS in Rs Rs. 5.66 Rs. 14.24 Rs. 19.53 + 37.15 % + 245.05 %


Today, we’re looking at SMS Lifesciences India Ltd’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 41.21 %. However, it did see a marginal increase of 24.9 % from the previous quarter. Expenses ticked up slightly by 25.29 % quarter-on-quarter, aligning with the annual rise of 27.96 %. Operating profit, while up 398.25 % compared to last year, faced a quarter-on-quarter increase of 22.28 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 9.04 %, but a shrinkage of -0.27 % sequentially. Other income rose by 308.62 % compared to the last quarter, despite an annual decline of -3.27 %. Interest expenses surged remarkably by 21.37 % from the previous quarter, yet the year-over-year increase remains at a moderate 57.78 %. Depreciation costs climbed by 1.34 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 29.45 %. Profit before tax grew annually by 71000 % but saw an increase from the preceding quarter by 87.11 %.
Tax expenses as a percentage of profits decreased slightly by -1.9 % compared to last year, with a more notable quarter-on-quarter increase of 0.61 %. Net profit rose by 207.11 % year-on-year but experienced a 57.28 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 245.05 % but a quarterly rise of 37.15 %. In summary, SMS Lifesciences India Ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 63.731 Cr Rs. 72.053 Cr Rs. 89.992 Cr + 24.9 % + 41.21 %
Expenses Rs. 61.45 Cr Rs. 62.76 Cr Rs. 78.63 Cr + 25.29 % + 27.96 %
Operating Profit Rs. 2.28 Cr Rs. 9.29 Cr Rs. 11.36 Cr + 22.28 % + 398.25 %
Net Profit Rs. 2.11 Cr Rs. 4.12 Cr Rs. 6.48 Cr + 57.28 % + 207.11 %
EPS in Rs Rs. 5.66 Rs. 14.24 Rs. 19.53 + 37.15 % + 245.05 %


In reviewing SMS Lifesciences India Ltd’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 41.21 % year-on-year growth, however, there was a minor increase of 24.9 % from the previous quarter. Expenses rose by 27.96 % compared to the previous year, with a 25.29 % increase quarter-on-quarter. Operating Profit surged by 398.25 % annually, and saw a 22.28 % increase from the last quarter.
Net Profit showed yearly increase of 207.11 %, and experienced a 57.28 % increase from the previous quarter. Earnings Per Share (EPS) rose by 245.05 % annually, however rose by 37.15 % compared to the last quarter. In essence, while SMS Lifesciences India Ltd exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”SMS Lifesciences India “]

Related Post